Cytokinetics, Inc. is a publicly traded biopharmaceutical company based in South San Francisco, California, that develops muscle activators as potential treatments for people with diseases characterized by impaired or declining muscle function.

Robert Blum
President & CEO
Robert Blum
Andrew A. Wolff
SVP, Chief Medical Officer
Anne N. Murphy
VP, Biology
Bonnie A. Charpentier
SVP, Regulatory Affairs and Compliance
Bradley P. Morgan
SVP, Research and Non-Clinical Development
Ching W. Jaw
SVP, Chief Financial Officer
Daniel E. Kates
VP, Medical Affairs
Daniel R. Casper
VP, Information Technology
David W. Cragg
SVP, Human Resources
Diane Weiser
SVP, Corporate Communications and Investor Relations
Elisabeth A. Schnieders
SVP, Business Development
Eric Terhaerdt
VP, Development Operations
Erin Donnelly
VP, Portfolio & Project Management
Fady I. Malik
EVP, Research and Development
Mark A. Schlossberg
SVP, Legal and General Counsel
Robert C. Wong
VP, Chief Accounting Officer
Scott R. Jordan
SVP, Global Marketing & Commercial Strategy
Stuart Kupfer
SVP, Chief Medical Officer
Andrew Callos
EVP, Chief Commercial Officer
Jennifer Laux
VP, Cardiovascular Marketing
Jeff Lotz
VP, Sales and Operations
Diann Potestio
VP, Global Value, Access & Distribution
Steven M. Cook
SVP, Commercial Supply Chain Operations

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.